The pharmaceutical and biotechnology sectors are poised for a significant leap forward in drug development with the formation of a…
Read More
Engineered exosomes from pig semen: a high-yield platform for non-invasive ocular drug delivery
Chinese researchers have unveiled a groundbreaking approach to treating ocular cancers, specifically retinoblastoma, through the development of specialized eye drops…
Read More
Canadian Researchers Identify Potential HIV Drug Repurposing to Combat Aggressive Glioblastoma Brain Tumors
In a landmark study that could redefine the treatment landscape for terminal brain cancer, a collaborative team of Canadian scientists…
Read More
Sai Life Sciences’ Biotech Pitch Day 2026 Spotlights Emerging Innovation and Forges Crucial Collaborations in the Drug Discovery Landscape
Boston, MA – Sai Life Sciences, a leading global contract research, development, and manufacturing organization (CRDMO), recently convened its highly…
Read More
Amazon Web Services Launches AI Drug Discovery Platform to Accelerate Novel Therapy Development
Amazon Web Services (AWS) has unveiled a groundbreaking artificial intelligence (AI) application designed to significantly accelerate the design and testing…
Read More
US Food and Drug Administration Unveils Draft Guidance for Genome Editing Therapies, Prioritizing Safety Through Next-Generation Sequencing
The US Food and Drug Administration (FDA) has issued draft guidance aimed at enhancing the safety assessment of genome editing…
Read More
Engineers and Physicians Develop Advanced Bone Marrow on a Chip to Revolutionize Drug Testing and Space Medicine
A multidisciplinary team of researchers from the University of Pennsylvania School of Engineering and Applied Science, the Perelman School of…
Read More
New York Times-lauded Medvi is marketing QUAD, a four-drug ED cocktail with a Parkinson’s drug component
QUAD is marketed by MEDVi as a sublingual, four-drug cocktail for erectile dysfunction, combining three well-known PDE5 inhibitors—sildenafil, tadalafil, and…
Read More
Novo Nordisk Forges Landmark AI Partnership with OpenAI to Revolutionize Drug Development Amidst Intensifying Competition
The pharmaceutical industry is witnessing an unprecedented surge in artificial intelligence (AI) adoption, with Novo Nordisk, a global leader in…
Read More
EU Drug Exports Surge in 2025, Setting Record Trade Balance Amidst Geopolitical Tensions
New figures released by the European Union (EU) reveal a significant surge in the value of pharmaceutical trade across the…
Read More
